Klingbiel, Dirk
F. Hoffmann-La Roche AG
2 papers on CoChatORCID 0000-0002-9914-0243
Most cited papers
- Verified
Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): a randomised, open-label phase II study
O'Shaughnessy, J., Sousa, S., Cruz, J., Fallowfield, L., Auvinen, P., Pulido, C., Cvetanovic, A., Wilks, S., Ribeiro, L., Burotto, M., et al. (2021) · European Journal of Cancer
HER2/EGFR in Cancer ResearchGastric Cancer Management and Outcomes
Cited by 83
- Verified
Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer
Yan, P., Klingbiel, D., Saridaki, Z., Ceppa, P., Curto, M., McKee, T. A., Roth, A., Tejpar, S., Delorenzi, M., Bosman, F. T., et al. (2016) · Clinical Cancer Research
Genetic factors in colorectal cancerTGF-β signaling in diseases
Cited by 78
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free